Shanghai Kinetic Medical Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Net Income	179.22	134.89	-105.57	112.54	-21.28	161.78
Depreciation & Amortization	67.06	67.06	69.52	65.83	60.9	56.81
Other Amortization	14.53	14.53	12.93	12.16	13.38	11.81
Loss (Gain) From Sale of Assets	-0.26	-0.26	0.1	0.37	0.21	-1.6
Asset Writedown & Restructuring Costs	0.38	0.38	2.91	0.58	200	149.4
Loss (Gain) From Sale of Investments	-82.83	-82.83	193.26	-30.63	28.9	-47.79
Provision & Write-off of Bad Debts	-	-	-	-8.96	19.66	11.5
Other Operating Activities	8.41	44.65	32.67	23.38	11.85	38.82
Change in Accounts Receivable	13.87	13.87	-60.96	-214.81	149.93	45.61
Change in Inventory	-13.82	-13.82	-29.1	-21.89	-49.65	-60.62
Change in Accounts Payable	11.64	11.64	67.22	336.82	-174.18	38.11
Change in Other Net Operating Assets	5.62	5.62	2.38	-	-	-26.98
Operating Cash Flow	197.18	189.09	157.75	274.26	236.76	378.16
Operating Cash Flow Growth	6.15%	19.86%	-42.48%	15.84%	-37.39%	32.72%
Capital Expenditures	-43.88	-66.2	-82.84	-53.79	-41.45	-49.21
Sale of Property, Plant & Equipment	4.8	4.58	0.29	0.49	0.84	4.87
Cash Acquisitions	5.4	-	-	-	-	-64.73
Divestitures	155.03	155.33	-	9.37	1.4	30.5
Investment in Securities	-325.77	-430.08	-509.42	-168.58	-132.14	-37.69
Other Investing Activities	86.36	70.91	69.64	11.85	8.59	7.04
Investing Cash Flow	-120.13	-267.53	-522.33	-186.67	-163.78	-109.22
Long-Term Debt Issued	-	225.67	310.26	175.7	172.82	293.08
Long-Term Debt Repaid	-	-239.45	-196.97	-346.01	-215.42	-456.71
Net Debt Issued (Repaid)	11.05	-13.79	113.29	-170.31	-42.6	-163.62
Common Dividends Paid	-3.42	-4.6	-46.14	-5.11	-47.23	-54.86
Other Financing Activities	10.79	14.62	2.71	-1.49	-14.26	-20.47
Financing Cash Flow	18.43	-3.77	69.86	-176.91	-104.09	-238.95
Foreign Exchange Rate Adjustments	-5.17	-3.63	0.85	1.67	11.97	-3.03
Net Cash Flow	90.31	-85.83	-293.87	-87.64	-19.14	26.96
Free Cash Flow	153.3	122.88	74.91	220.47	195.3	328.94
Free Cash Flow Growth	68.01%	64.04%	-66.02%	12.89%	-40.63%	28.84%
Free Cash Flow Margin	17.64%	12.76%	7.61%	23.06%	16.75%	25.93%
Free Cash Flow Per Share	0.21	0.17	0.10	0.31	0.27	0.46
Cash Interest Paid	1.33	1.33	0.54	0.18	0.85	2.31
Cash Income Tax Paid	64.59	47.38	36.17	63.87	131.29	123.06
Levered Free Cash Flow	238.34	109.43	55.1	190.28	160.13	-135.88
Unlevered Free Cash Flow	243.01	114.1	59.27	194.38	168.96	-121.71
Change in Working Capital	10.67	10.67	-48.06	98.99	-76.86	-2.57

Source: S&P Global Market Intelligence. Standard template. Financial Sources.